Sorry, you need to enable JavaScript to visit this website.

INVEGA TRINZA® Extrapyramidal Symptoms Data | HCP

INVEGA TRINZA® Extrapyramidal Symptoms Data Observed1

Extrapyramidal Symptoms (EPS) Data: Long-term Maintenance Trial1

EPS-Related Reactions by MeDRA-preferred Term1

extrapyramidal

MedDRA=Medical Dictionary for Regulatory Activities

*During the open-label phase, patients received several doses of INVEGA SUSTENNA® (paliperidone palmitate) followed by a single dose of INVEGA TRINZA®.

†Parkinsonism group included: cogwheel rigidity, drooling, extrapyramidal disorder, hypokinesia, muscle rigidity, muscle tightness, musculoskeletal stiffness, parkinsonism.

‡Hyperkinesia group included: akathisia, restlessness.

§Dystonia group included: blepharospasm, dystonia, muscle spasms.

Reference: 1. INVEGA TRINZA® [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc.; August 2021.